HALL A
10 January 2023
HALL B
10 January 2023
SAUDI 1
10 January 2023
SAUDI 2
10 January 2023
HALL D (Sharjah Uni)
10 January 2023
INAUGRATION OF EXHIBITION
ASHP PROGRAM
Prof. Mahmoud Marashi | Consultant Haematologist, Rashid Hospital /DHA, Dubai| United Arab Emirates

Array Mahmoud Marashi
Consultant Haematologist, Rashid Hospital /DHA, Dubai | United Arab Emirates
Consultant Haematologist, Rashid Hospital /DHA, Dubai
Sessions by this speaker
Thursday,
-
Optimizing Patient Care by Leveraging the Connection of Pharmacists in the Inpatient, Ambulatory, and Retail Settings.

Dr. Tammy S. Cohen,
BS, PharmD, MS, FASHP, FTSHP, FACHEVice President of Pharmacy, Baylor, Scott & White Health, Texas, | USA
Tammy S. Cohen, BS, PharmD, MS, FASHP, FTSHP, FACHE is the Vice- President of Pharmacy Services at Baylor Scott and White Health in Dallas, Texas. Her responsibilities span pharmacy practice across many settings to include ambulatory care, inpatient and retail practice sites. She oversees the pharmacy services of the 27 hospitals and 31 retail pharmacy locations within BSWH. Tammy leads and serves on many multi-disciplinary committees and has been instrumental in leading financial and operational efficiencies that cross the organization and implementing clinical services. Tammy has been active in several pharmacy organizations. She has been a member of the Texas Society of Health System Pharmacists (TSHP) Board of Directors in various capacities since 2006; most recently she served as the Immediate-Past President. She is also currently a member of the American Society of Health System Pharmacists (ASHP) Pharmacy Executive Leadership Academy. Additional previous TSHP roles include: serving as chair of the Council of Organizational Affairs, Chair of the Section of Pharmacy Management, member of the TSHP Education Council and as the TSHP representative to the Texas State Board Pharmacy (TSBP) Task Force on Internships. Additional organization activities include formal roles with ASHP and the local societies of health system pharmacy along with numerous regulatory related task forces. ASHP experiences include serving on the Council on Legal and Public Affairs, a member of the steering committee for the ASHP Leadership Meeting, the Chair of the Advisory Group on Publications for the Section for Inpatient Practitioners and a member of the Section of Financial Management for the Section of Pharmacy Practice Management. "
Lectures by this speaker
Tuesday, 2023-01-10
Optimizing Patient Care by Leveraging the Connection of Pharmacists in the Inpatient, Ambulatory, and Retail Settings.
11:00 - 11:45
Wednesday, 2023-01-11
A Journey to a Resilient and Thriving Pharmacy Workforce (ASHP Workshop)
13:30 - 14:30
11:00 - 11:45
Credentialing and Privileging Pharmacists – A Framework for Practice Advancement

Dr. Trisha A. Jordan
PharmD, MS, Chief Pharmacy Officer, Ohio State University Wexner Medical Cente, | USA
"Trisha A. Jordan, PharmD, MS is currently the Chief Pharmacy Officer and Director for the Health-System Pharmacy Administration Residency Program at The Ohio State University Wexner Medical Center and Assistant Dean for Medical Center Affairs at the OSU College of Pharmacy. In her role, Trisha leads pharmacy services across the enterprise, with a focus on providing patient centered pharmacy care through innovation, education and research. After completing undergraduate studies, Trisha received her doctor of pharmacy degree from the University of Michigan and a Master’s degree in health-system pharmacy administration from The Ohio State University. She also completed a pharmacy administration residency at Ohio State and earned a Lean Six Sigma Green Belt certification through the Fisher College of Business at The Ohio State University. Trisha’s professional goals have centered on improving patient care outcomes by creating advanced pharmacy practice models to improve the safety and efficacy in medication use. Her research focuses on pharmacy services and their effect on quality, safety, and cost in addition to the impact of the changing role of the pharmacist in health-systems. She is involved in professional pharmacy organizations and dedicates time to advocacy efforts at the state and national level.
Lectures by this speaker
Tuesday, 2023-01-10
Credentialing and Privileging Pharmacists – A Framework for Practice Advancement
11:45 - 12:30
Wednesday, 2023-01-11
A Journey to a Resilient and Thriving Pharmacy Workforce (ASHP Workshop)
13:30 - 14:30
11:45 - 12:30
Pharmacy in the Middle: The Roles Played in a Mass Vaccination Site and Cleanroom Quality

Dr. Majid R. Tanas
PharmD, MHA, MS, FASHP, Vice President of Pharmacy & Chief Pharmacy Officer for Legacy Health. | USA
Dr. Tanas has sought to help others in the profession by mentoring, speaking at conferences, and elevating pharmacy practice at the state and national level. In 2009, Dr. Tanas helped lead the remediation of Oregon Board of Pharmacy findings of non-compliance for Remote IV Dispensing. Through this effort, statutes for Oregon were developed to support Remote IV Dispensing - many of which became a model for others to reference. By this endeavor, oncology-trained Health-System Pharmacists remotely managed Pharmacy Technicians in cleanrooms across 100 miles of freeway. This model allowed Pharmacy Technicians to practice at a higher level as they were able to function independently. As a part of Specialty Pharmacy expansion within Oregon, Dr. Tanas spearheaded the Specialty Pharmacy team to expand critical specialty medications to Oregonians by achieving URAC accreditation, building a specialty program, and developing ambulatory practices to reach more patients. In 2015, The National Institutes of Health Clinical Center had significant FDA 483 findings in their cleanroom. This impact halted much of NIH-sponsored research. After a nationwide search, Dr. Tanas was selected to become the Chief of Pharmacy due to his cleanroom and remediation expertise. During his tenure, he established a team to address significant operational changes to modernize current regulatory practice standards, design the first Health-System cGMP compliant 503A cleanroom, increase the department FTE by nearly double, and expand resources for research. In the midst of a challenging transition, Dr. Tanas made the difficult decision to issue a nationwide recall for medications due to quality concerns. His leadership ultimately led the NIH Clinical Center to initiate a medication safety and quality program and instituted daily organization-wide safety huddles. Currently, Dr. Tanas leads a multi-hospital health system at Legacy Health Pharmacy Services to elevate their cleanroom and regulatory practices. He has directed remodels at five hospitals across the region, upgraded to automated dispensing cabinets for safer medication delivery systems, established a technician-led compliance team for diversion prevention, achieved URAC/ACHC Specialty Pharmacy accreditation, and expanded 340b outpatient clinic services. During the pandemic, his leadership and collaboration with adjoining health systems across the region resulted in the nation's fifth-largest mass vaccination site. Throughout his career, Dr. Tanas has exemplified a commitment to patient safety and compliance by creating unique systems to deliver pharmaceutical care. He continues to give back to the pharmacy community by mentoring student and resident pharmacists to challenge their paradigm around patient care. In addition, he creates opportunities for both technicians and pharmacists to advance their careers in unique care models.
Lectures by this speaker
Tuesday, 2023-01-10
Pharmacy in the Middle: The Roles Played in a Mass Vaccination Site and Cleanroom Quality
12:30 - 13:15
Wednesday, 2023-01-11
A Journey to a Resilient and Thriving Pharmacy Workforce (ASHP Workshop)
13:30 - 14:30
12:30 - 13:15
SCIENTIFIC RESEARCH FREE PAPERS (A1)
Scientific Research presentation - free papers
The impact of a combined aerobic and resistance exercise programmeme in preventing or delay to the onset of diabetes (18): Bandar Alharbi, Director of the Pharmaceutical services department at Prince Sultan Military Medical City.
Importance of Reporting Adverse Drug Reaction in Improving patient safety (42) Ms. Dima Kamal Zeineddine, Clinical Pharmacist, Kimshealth Hospital, Oman
Adverse Events that result in Emergency Department visits among cancer patients receiving chemotherapy in the outpatient settings: Characteristics and Outcomes (53) : Ms. Naheel Meichail Najib Said, Resident Pharmacist, King Hussein Cancer Center, JORDAN
13:30 - 17:30
Scientific Research presentation - free papers (A1)
Spray-Dried, Biodegradeable, Drug-Loaded Microspheres for use in Treatment Microspheres for use in the Treatment of Lung Diseases(22) : Dr. Maze Gharsan Al Gharsan, Pharmacist officer, Armed forces hospital, KSA
Retrospective Review: Remdesevir Impact on Rdmission & Mortality in Acute Care (61) : Ms. Ruby Rajkumar, Clinical Informatics Pharmacy Manager, St Johns Episcopal Hospital, USA
“Outcomes of Antimicrobial Stewardship Program in the prevention of antibiotics misuse in patients with Spinal Cord Injury undergoing minor urologic procedures” (56).Ms. Lina I. Alnajjar, Vice-dean, Assistant Professor, Princess Nourah bin Abdulrahman University, Saudi Arabia
14:15 - 17:30
SCIENTIFIC RESEARCH FREE PAPERS (A1)
Scientific Research presentation - free papers (A1)
Oral bio availability enhancement of Papain by Novel Nanostructured Lipid Carriers formulation development and its quality stricture evaluation (90) Dr. Jeyaprakash M R, Assistant Professor in the Department of Pharmaceutical, JSS College of Pharmacy, INDIA.
Segmentation Tool Using Advanced Analytics to Move from Traditional Segmentation to Customer Persona Approach (319) : Mr. Martina Ashraf, Research manager, Accsight L.L.C, EGYPT
Incidence of Chemotherapy-Induced Neurotoxicity among Older and Younger Patients with Breast Cancer (384) : Mr. Eman Ahmed Mohammed, B.pharm graduate, Jaber al-ahmed hospital, kuwait
13:30 - 17:30
MEDICINE SAFETY
Prof. Abdullah Al Khayat | Dubai| United Arab Emirates

Array Abdullah Al Khayat
Dubai | United Arab Emirates
Dubai UAE
Sessions by this speaker
Thursday,
-
Medicine Safety and Quality Use of Medicines during Medicine Shortages
Mr. Jerry Yik | MPubPol, Head of Policy and Advocacy, SHPA, | Australia

Mr. Jerry Yik
MPubPol, Head of Policy and Advocacy, SHPA, | Australia
Jerry leads SHPA’s diverse policy and advocacy activities, highlighting health and pharmacy policy issues to the relevant stakeholders including parliamentarians, government departments, regulatory bodies, clinical and safety agencies. Harnessing member expertise, SHPA's Policy and Advocacy team demonstrates the continuing expertise, innovation and high standard the hospital pharmacy sector sets, as well as the challenges faced by the sector to provide high quality, safe, equitable and accessible pharmacy services to Australian patients in all healthcare settings.
Lectures by this speaker
Tuesday, 2023-01-10
Medicine Safety and Quality Use of Medicines during Medicine Shortages
11:00 - 11:45
Thursday, 2023-01-12
How do we Support Medicine Safety and Quality Use of Medicines During Medicine Shortages
09:30 - 10:30
11:00 - 11:45
Determining the Actual Cost of Drug Counterfeiting
Prof. Albert Wertheimer | PhD, MBA,Nova Southeastern University | USA

Prof. Albert Wertheimer
PhD, MBA,Nova Southeastern University | USA
Dr. Albert Wertheimer has been active in sociobehavioral and administrative pharmacy research and education for more than 30 years. He earned a pharmacy degree at the University of Buffalo, an M.B.A. from the State University of New York at Buffalo and his Ph.D. at Purdue University. In addition, he completed a post-doctoral research fellowship in the department of social medicine at St. Thomas” Hospital Medical School of the University of London. He has directed nearly 100 Ph.D. students and more than that number of master’s students. He is the author or editor of 40 books, numerous book chapters and about 430 journal articles. He has lectured or consulted in about 75 countries, and he holds visiting professor appointments at universities in Mexico, Taiwan, Turkey, Slovenia and China. He performed pioneering work in the area of social and behavioral sciences in pharmacy and in more recent years has conducted research in pharmaco-economics, outcomes research, and health policy analysis. Prior to his appointment at NSU, he has been a professor at Temple University, dean of the Philadelphia College of Pharmacy, a researcher at Merck and Company, a vice president of First Health, Inc., a Pharmacy Benefit Manager and a professor and director of graduate studies at the University of Minnesota. Dr. Wertheimer has received many awards and recognitions including fellowships from the American Association of Pharmaceutical Scientists and the International Pharmacy Federation (FIP). He is Scheele Laureate and an honorary member of several professional societies. He has been a study section member/grant reviewer for the US NIH and for AHRQ. Current research interests include pharmaceutical counterfeiting, off label prescribing and cost:benefit studies.
Sessions by this speaker
Wednesday, 2023-01-11
ADVANCES IN PHARMACOTHERAPY 1
09:00 - 10:30
Lectures by this speaker
Tuesday, 2023-01-10
Determining the Actual Cost of Drug Counterfeiting
11:45 - 12:30
Thursday, 2023-01-12
Getting your Research Published in a Journal
12:30 - 13:30
11:45 - 12:30
Controlled Substances Diversion by Prescription – What to look for to prevent diversion

Dr. Diane B. Ginsburg
Ph.D., M.S., R.Ph., FASHP Professor, Pharmacy Practice, Associate Dean for Healthcare Partnerships, The University of Texas at Austin, College of Pharmacy, | USA
Dr. Ginsburg completed her B.S. in Pharmacy at the University of Pittsburgh School of Pharmacy and M.S. at the University of Houston College of Pharmacy. She completed a two-year ASHP-accredited residency in hospital pharmacy administration at The Methodist Hospital in Houston, Texas. She received her Doctor of Philosophy degree in higher education administration and leadership in the College of Education at the University of Texas at Austin. She is currently Clinical Professor in the Pharmacy Practice Division, Associate Dean for Healthcare Partnerships, and G.D. Searle Endowed Fellow in Pharmacy at the University of Texas at Austin, College of Pharmacy. She is an adjunct instructor in the Drug Enforcement Administration Teaching Academy and a Gallup-Certified Strengths Coach.
Lectures by this speaker
Tuesday, 2023-01-10
Controlled Substances Diversion by Prescription – What to look for to prevent diversion
12:30 - 13:15
12:30 - 13:15
SCIENTIFIC RESEARCH FREE PAPERS (B1)
Scientific Research presentation - free papers (B)
A theoretical exploration of the implementation of antimicrobial stewardship programmes: perspectives of key stakeholders underpinned by the Consolidated Framework for Implementation Research (66) :Ms. Nortan Hashad, PhD researcher in Robert Gordon University (RGU), School of Pharmacy and Life Sciences, Aberdeen, Scotland, UK.
Knowledge, Attitude and practice of Physicians towards the use of Influenza Vaccine in Chronic Obstructive Pulmonary Disease in UAE (50): Ms. Aisha Ali saeed Almotairy, Fujairah hospital and in charge of OPD-pharmacy.UAE
Medication-Related Problems in Clinical Practice: A Hospital-Based Prospective Observational Study (64) : Dr. Jalpa Suthar, Associate Professor at, Department of Pharmacology & Clinical Pharmacy, Ramanbhai Patel College of Pharmacy, India
13:30 - 17:30
Scientific Research presentation - free papers (B1)
Pharmacist - Hamad Town Pharmacy Group, Member of Bahrain Pharmacists Society (135), Mr. Ali Ahmed AlTahoo, Class representative of the B.Sc. in Pharmacy program, University of Bahrain. BAHRAIN
Impact of a Pharmacist-driven Antimicrobial Stewardship Program at a Community Teaching Hospital (44), Piao Zhuge, PharmD, Clinical Pharmacy Manager, St. John’s Episcopal, USA
Design & Synthesis of Selected Novel 4- Thiazolidinone Derivatives as SIRT-3 Enzyme Activators Targeting Parkinson’s disease (47) : Dr. Gomathy S, Associate Professor, JSS College of Pharmacy, India
14:15 - 17:30
Scientific Research presentation - free papers
Living with Alzheimer - Regional Study (316)Mr. Rehem Adel, Accsight L.L.C, EGYPT
Evaluating the Microbiological Profile and Outcomes of Bacteremia in Adult Cancer Patients at Hospital Admission(299) Ms. Tamara Ahmad Seif, Pharmacy resident, King Hussein Cancer Center (KHCC), Jordan
Assessment of Perceived Causes of Psychological Distress in Response To COVID-19 Pandemic among the Medical and Health Sciences University Students in Ras Al Khaimah- A Cross Sectional Study, (315) Ms. Areeg Anwer Ali, RAK College of Pharmacy, RAK Medical & Health Sciences University, UAE
15:00 - 17:30
Infectious Disease Pharmacotherapy Update

Array Abdullah Mohammed Al-Zahrani
Pharm.D. Consultant Clinical Pharmacist / Pharmacotherapy of Nephrology Director of Pharmacy Services Security Forces Hospital Program | Saudi Arabia
Dr.Alzahrani is a Consultant Clinical Pharmacist in Nephrology Pharmacotherapy, Currently is Director of Pharmacy Services Department at Security Forces Hospital(SFHP) – Riyadh, Saudi Arabia Dr.Alzahrani is scientific council member and member of central accreditation committee Saudi commission for health speciality(SCFHS) Dr. Alzahrani obtained his Doctorate of Pharmacy (Pharm.D.) degree from Campbell University, North Carolina, U.S.A in 2001, then he joins the ASHP General Pharmacy Practice Residency at Florida Hospital, Orlando, Florida U.S.A in 2002 In 2007, Dr. Al Zahrani started his own ambulatory clinic for management of post-renal transplant patient and hepatitis C patients. He is a member of many committees in hospital and nationally In 2011 Dr. Al-Zahrani joined the Saudi Pharmaceutical Society Board as the Management Board Secretary and the Chairman of Membership and Branches Committee. In 2014 Dr. Al-Zahrani elected to join the Saudi Pharmaceutical Society for another cycle. In 2017 Dr. Alzahrani elected as member of Saudi Pharmaceutical Society Board as the 3rd cycle Dr. Al-Zahrani presented a number of presentations over the years locally and internationally.
Sessions by this speaker
Thursday,
-
Updates in the Management of Invasive Fungal Infections

Dr. Sarah S. Almuhisen,
Pharm.D., BCIDP Infectious Diseases Clinical Pharmacist King Fahad Medical City (KFMC) Riyadh, | Saudi Arabia
Sarah Almuhisen, PharmD, BCIDP is an Infectious disease clinical pharmacist at King Fahad Medical city (KFMC), Riyadh. She is American and Saudi Board Certified in Infectious Disease pharmacotherapy (BCIDP), Antimicrobial Stewardship Pharmacist from American Society of infectious disease pharmacists (SIDP). She is completed PGY1 Pharmacy Practice Residency at King Fahad medical city then completed PGY2 Infectious Disease pharmacy residency at Prince Sultan Military Medical City (PSMMC). Pharm. D graduated from Princess Nora bint Abdulrahman University College of Pharmacy with first class honors. Currently, she is an active board member in infectious disease pharmacy specialty network (ID-PSN) in Saudi Society of Clinical Pharmacy (SSCP) as well as member in antimicrobial stewardship committee at KFMC.
Lectures by this speaker
Tuesday, 2023-01-10
Updates in the Management of Invasive Fungal Infections
11:00 - 11:45
11:00 - 11:45
Updates in the Management of Antimicrobial Resistant Gram-negative Infections

Dr. Thamer A. Almangour,
Pharm.D., BCPS, BCIDP Asst. Prof, Infectious Diseases Pharmacotherapy Consultant & Director, Infectious Diseases Pharmacy Residency Program, King Saud University | Saudi Arabia
Dr. Thamer Almangour graduated with bachelor’s degree of pharmaceutical science from King Saud University where he started his career as a teaching assistant. He graduated with Doctor of Pharmacy degree from Massachusetts, followed by a residency from Massachusetts General Hospital, Boston, Massachusetts. He completed a second year of specialty residency in infectious diseases from Midtown Medical Center, Columbus, Georgia. He also completed 2 years of post-doctoral fellowship in infectious diseases from University of North Carolina at Chapel Hill. He is board certified in pharmacotherapy and board certified in infectious diseases. He has around 40 publications and book chapter in the area of infectious diseases. He started his professional career as Assistant Professor in the college of pharmacy at King Saud University, Riyadh, Saudi Arabia in 2019 and consultant clinical pharmacy specialist in the area of infectious diseases in King Saud University Medical City. He became the PharmD internship program supervisor at the college of pharmacy and the infectious diseases pharmacy residency program director at the University Hospital
Lectures by this speaker
Tuesday, 2023-01-10
Updates in the Management of Antimicrobial Resistant Gram-negative Infections
11:45 - 12:30
11:45 - 12:30
Updates in the Management of Sepsis and Septic Shock

Dr. Saleh Saeed Alzahrani
Pharm.D., BCCCP Clinical Pharmacist Specialist-Adult Critical Care Pharmacy Services Department Security Forces Hospital Program | Saudi Arabia
Clinical Pharmacist Specialist – Adult Critical Care, Pharmacy Services, Security Forces Hospital Program – Riyadh. Saleh Alzahrani is a Critical Care Clinical Pharmacist at Security Forces Hospital Program - Riyadh, he earned his Doctor of Pharmacy (Pharm.D) degree from King Abdulaziz University in 2009. He has done his PGY-1 clinical pharmacy at Security Forces Hospital Program – Riyadh in 2013 - 2015, and his PGY-2 in Critical Care at King Saud University Medical City in 2021 - 2022. Dr. Alzahrani became an American Board-Certified Critical Care Pharmacist (BCCCP) in 2018.
Sessions by this speaker
Thursday, 2023-01-12
Internal Medicine Pharmacotherapy Update
11:00 - 13:15
Lectures by this speaker
Tuesday, 2023-01-10
Updates in the Management of Sepsis and Septic Shock
12:30 - 13:15
12:30 - 13:15
Medication Safety: New Insights
Mr. Siraj O Abid | B.Pharm. MBA Consultant Pharmacist| Saudi Arabia

Array Siraj O Abid
B.Pharm. MBA Consultant Pharmacist | Saudi Arabia
He has Bachelor of Pharmaceutical sciences: College of Pharmacy KING SAUD UNIVERSITY in Riyadh 1995 and Post-Graduation of business Administration: Leicester University 2010. with Excellent experiences gained through twenty five plus years of working in pharmaceutical and consumer goods field through sales, credit controlling, team building and management, resources management, forecasting, planning of actions, logistics, supply chain management, collection, regulatory affairs, manufacturing, quality, finance analysis, training and high management. Excellent development through sales career started as sales rep to sales and credit controlling manager then Regional general manager in a company listed as one of the begets pharmaceutical institution in Saudi Arabia. Licensed as Pharmaceutical Consultant from Ministry of Commerce and Industry
Sessions by this speaker
Thursday,
-
Sustainability in Preparation of Accreditation for CBAHI and JCI for Medication Safety Enhancement

Dr. Saleh Ayed Al Anazi
Manager of Quality Improvement Pharmaceutical Care Services King Abdulaziz Medical City Riyadh, | Saudi Arabia
Manager Quality pharmaceutical care services in King Abdulaziz medical city in Riyadh. Faculty member at the College of Pharmacy, King Saud bin Abdulaziz University for Health Science. Adjunct assistant professor at Almaarefa University. Adjunct assistant professor at Prince Sattam Bin Abdulaziz University. Surveyor in Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) in pharmacy. Hold Ph.D. degree in pharmaceutical science from King Saud University 2020, hold master degree in pharmaceutical science from king Saud University 2015, and master degree in total quality management from The Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt 2006. Also Certified Patient Safety Officer (CPSO), AIHQ since April 2015, with lots of Courses inpatient and medication Safety and quality. Certified CPHQ September 2016. Lean Six Sigma Yellow Belt Certified February 18 -19th, 2015, Lean Six-Sigma Green Certified February 20 -22, 2015. Member in Medication Safety Program in National Guard.
Lectures by this speaker
Tuesday, 2023-01-10
Sustainability in Preparation of Accreditation for CBAHI and JCI for Medication Safety Enhancement
11:00 - 11:45
11:00 - 11:45
Poly-pharmacy a Medication Safety Concern in Cardiac & Chronic Patients

Dr. Fakhr Z. AlAyoubi,
M.Sc., R Pharm, MBA President, of Cardio Clinical Pharmacy Group Saudi Heart Association, Clinical Pharmacist Adjunct Asst. Prof, College of Pharmacy, King Saud University | Saudi Arabia
Credentials: Master's in business administration, master's in clinical pharmacy, Board in Heart Failure, and Arab Board in Cardiology Pharmacy Specialty. Work Experience: Currently, President of the Cardiology Pharmacy Group at the Saudi Heart Association Pharmacy. the research head of metabolic syndrome, pharmacotherapy, and clinical practice, with more than 30 publications, in international and national journals, one of the most important bleeding risks score multivariable modules for Non-Valvular Atrial Fibrillation using Direct Oral Thrombin Inhibitor (DOAC) in the Arab population. Previous: Head of Ambulatory care, & Head of Clinical Pharmacy Server at King Khalid University Hospital. Conducted numerous clinical trials, established, and implemented different national guidelines and multi-disciplinary programs
Lectures by this speaker
Tuesday, 2023-01-10
Poly-pharmacy a Medication Safety Concern in Cardiac & Chronic Patients
11:45 - 12:30
11:45 - 12:30
A Practical Method for Evaluation of Isotretinoin Medication Safety in Pediatric Oncology Patients: A case Study of Neuroblastoma

Dr. Miteb Alanazi
B.Sc. (Pharm.), M.Sc. Hematology, Oncology Pediatric Clinical Pharmacist Drug& Poison Information Center Adjunct Clinical Assistant Professor King Saud University Medical City | Saudi Arabia
Miteb Alanazi is a senior pediatric oncology clinical pharmacist at King Saud University Medical City. He started his career in the pharmacy field since 2003. Dr. Miteb earned his master degree in clinical pharmacy from the pharmacy college at King Saud University. He acted as out-patient pharmacy assistant director from 2011-2015. Also, he was the director of pharmacy research center and toxicology lab from 2011-2013. Dr. Miteb is an active member of many professional societies such as “Saudi Oncology Pharmacy Assembly”, “American Association of College of Pharmacy”, and “Saudi Pharmaceutical Society”. Additionally, Dr. Miteb is the co-chair for the Vaccine Advisory Committee at King Saud University Medical City. Beside his professional duties, Dr. Miteb is participating in teaching and training numerous courses and students from different colleges of pharmacy
Lectures by this speaker
Tuesday, 2023-01-10
A Practical Method for Evaluation of Isotretinoin Medication Safety in Pediatric Oncology Patients: A case Study of Neuroblastoma
12:30 - 13:15
12:30 - 13:15
Pharmacy Practice I

Array Mohammad Alqudah
Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates
-
Sessions by this speaker
Thursday,
-
Role of Telepharmacy in Light of COVID-19

Prof. Osama Ibrahim
Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
Role of Telepharmacy in Light of COVID-19
11:00 - 11:25
11:00 - 11:25
Improving healthcare delivery for people with mental health: how community pharmacists can contribute

Dr. Hamzah Tareq Al Zubaidi
Department of Pharmacy Practice & Pharmacotherapy, College of Pharmacy, University of Sharjah | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
Improving healthcare delivery for people with mental health: how community pharmacists can contribute
11:30 - 11:55
11:30 - 11:55
The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge

Dr. Nadia AL Mazrouei
Department of Pharmacy Practice & Pharmacotherapy, College of Pharmacy, University of Sharjah | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge
12:00 - 12:25
12:00 - 12:25
A pharmacist-led inhaler technique training program for nurses: a case study from the United Arab Emirates

Prof. Eman Abu-Gharbieh
Sharjah Institute for Medical Research, University of Sharjah, Department of Clinical Sciences, College of Medicine, University of Sharjah | United Arab Emirates
-
Lectures by this speaker
Tuesday, 2023-01-10
A pharmacist-led inhaler technique training program for nurses: a case study from the United Arab Emirates
12:30 - 12:55
12:30 - 12:55
Pharmacy Practice II

Array Rania Harati
Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates
-
Sessions by this speaker
Thursday,
-
Pharmacists’ Involvement in Breast Cancer Health promotion

Dr. Rana Ibrahim
Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, College of Pharmacy, | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
Pharmacists’ Involvement in Breast Cancer Health promotion
15:45 - 16:10
15:45 - 16:10
Risk Factors Associated with Dyslipidemia Control in Low Income Patients

Dr. Mohd Shara
Dept. of Pharmacy Practice & Pharmacotherapeutics, University of Sharjah, College of Pharmacy | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
Risk Factors Associated with Dyslipidemia Control in Low Income Patients
16:15 - 16:40
16:15 - 16:40
Self-treatment during the COVID-19 pandemic in Arab countries

Dr. Feras Jassim Jirjees
Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates
.
Lectures by this speaker
Tuesday, 2023-01-10
Self-treatment during the COVID-19 pandemic in Arab countries
16:45 - 17:10
16:45 - 17:10
Counselling Children - How and When to Communicate with Children of Different Ages?

Dr. Khalid Al Kubaisi
Visiting Lecturer, Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah | United Arab Emirates
.